Health :: HIV/AIDS

Fauci touts HIV plan at confab

Fauci touts HIV plan at confab

  • by Liz Highleyman
  • Mar 6, 2019

Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases fleshed out a proposed national HIV plan at the opening session of the Conference on Retroviruses and Opportunistic Infections this week in Seattle.

SF health officials embrace non-daily PrEP dosing regimen

SF health officials embrace non-daily PrEP dosing regimen

  • by Matthew S. Bajko
  • Feb 27, 2019

As health officials continue to urge more people at risk of becoming HIV-positive to take PrEP, the once-a-day pill that widely protects against being infected with the virus if taken as prescribed, San Francisco leaders are embracing a new dosing regimen

New PrEP data show nearly 30 percent rise

New PrEP data show nearly 30 percent rise

  • by Liz Highleyman
  • Nov 28, 2018

The number of people taking PrEP rose by nearly 30 percent from 2016 to 2017, but disparities remain, according to updated figures released this week by AIDSVu.

SF to expand HIV homeless services

SF to expand HIV homeless services

  • by Alex Madison
  • Oct 31, 2018

San Francisco will receive a grant from the Centers for Disease Control and Prevention to help close gaps and mitigate barriers in HIV prevention and care services, particularly among homeless people.

Recent studies confirm PrEP benefits — and barriers to wider access

Recent studies confirm PrEP benefits — and barriers to wider access

  • by Liz Highleyman
  • Oct 24, 2018

PrEP is highly effective as an HIV prevention tool, but barriers to wider access are limiting its full potential, according to recent studies.

Rare PrEP failure reported at confab

Rare PrEP failure reported at confab

  • by Liz Highleyman
  • Oct 17, 2018

A San Francisco man is the sixth known case of PrEP failure despite consistent use of Truvada, researchers from the Department of Public Health and UCSF reported at the IDWeek conference held in San Francisco earlier this month.

Study: PrEP and HIV testing underused

Study: PrEP and HIV testing underused

  • by Liz Highleyman
  • Sep 26, 2018

Only 4 percent of sexually active gay and bisexual men in the United States are using PrEP, according to a recently published study, showing that more must be done to reach everyone who could benefit from it.

FDA approves new HIV meds

FDA approves new HIV meds

  • by Liz Highleyman
  • Sep 12, 2018

The U.S. Food and Drug Administration has approved two new HIV treatment medications containing doravirine, a next-generation non-nucleoside reverse transcriptase inhibitor.

Annual HIV report highlights disparities, declining numbers

Annual HIV report highlights disparities, declining numbers

  • by Liz Highleyman
  • Sep 5, 2018

The latest San Francisco HIV epidemiology report shows that while the number of new infections continues to decline, African-Americans and homeless people have persistently higher infection rates and poorer outcomes.

HIV suppression improves, but gaps remain

HIV suppression improves, but gaps remain

  • by Liz Highleyman
  • Aug 29, 2018

The proportion of people with HIV who achieve viral suppression has risen dramatically across the United States over the past two decades, but young black men are not seeing the same gains, according to a new study.

Research suggests policies are barrier to ending HIV

Research suggests policies are barrier to ending HIV

  • by Liz Highleyman
  • Aug 1, 2018

Government policies can work against achieving an end to HIV by limiting access to prevention and treatment for the most heavily affected groups, according to research presented at the 22nd International AIDS Conference last week in Amsterdam.

Activists want next AIDS confab out of Bay Area

Activists want next AIDS confab out of Bay Area

  • by Liz Highleyman
  • Jul 25, 2018

Activists kicked off this week's 22nd International AIDS Conference in Amsterdam with calls to move the next confab out of the San Francisco Bay Area.

New campaign promotes PrEP for Latinos

New campaign promotes PrEP for Latinos

  • by Liz Highleyman
  • Jun 6, 2018

A new Spanish-language PrEP campaign has launched to raise awareness about the HIV prevention pill in Latino communities.

FDA approves PrEP for adolescents

FDA approves PrEP for adolescents

  • by Liz Highleyman
  • May 16, 2018

The U.S. Food and Drug Administration this week approved Truvada PrEP for adolescents, making the once-daily HIV prevention pill more widely available to a group with a disproportionately high risk of infection.